Nebido 1000 mg/4 ml otopina za injekciju Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

nebido 1000 mg/4 ml otopina za injekciju

bayer d.o.o., radnička cesta 80, zagreb, hrvatska - testosterondekanoat - otopina za injekciju - 1000 mg/4 ml - urbroj: 1 ml otopine za injekciju sadrži 250 mg testosteron undekanoata što odgovara 157,9 mg testosterona

Testarzon 20 mg/g transdermalni gel Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

testarzon 20 mg/g transdermalni gel

the simple pharma company limited, ground floor, 71 lower baggot st, dublin, irska - testosteron - transdermalni gel - 20 mg/g - urbroj: jedan gram gela sadrži 20 mg testosterona jedan potisak na pumpici istiskuje 1,15 g (1,25 ml) gela što odgovara 23 mg testosterona

Androgel 50 mg transdermalni gel u vrećici Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

androgel 50 mg transdermalni gel u vrećici

besins healthcare s.a., rue washington 80, ixelles, belgija - testosteron - transdermalni gel u vrećici - 50 mg - urbroj: jedna vrećica (5 g gela) sadrži 50 mg testosterona

VITROS Immunodiagnostic Products Testosterone Controls Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

vitros immunodiagnostic products testosterone controls

pliva hrvatska d.o.o. za razvoj, proizvodnju i prodaju lijekova i farmaceutskih proizvoda prilaz baruna filipovića 25 10000 zagr -

VITROS Immunodiagnostic Products Testosterone Calibrators Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

vitros immunodiagnostic products testosterone calibrators

pliva hrvatska d.o.o. za razvoj, proizvodnju i prodaju lijekova i farmaceutskih proizvoda prilaz baruna filipovića 25 10000 zagr -

Firmagon Europska Unija - hrvatski - EMA (European Medicines Agency)

firmagon

ferring pharmaceuticals a/s - degarelix - prostatske neoplazme - endokrinska terapija - firmagon is a gonadotrophin releasing hormone (gnrh) antagonist indicated:- for treatment of adult male patients with advanced hormone-dependent prostate cancer. - for treatment of high-risk localised and locally advanced hormone dependent prostate cancer in combination with radiotherapy. - as neo-adjuvant treatment prior to radiotherapy in patients with high-risk localised or locally advanced hormone dependent prostate cancer.

Degarelix Accord Europska Unija - hrvatski - EMA (European Medicines Agency)

degarelix accord

accord healthcare s.l.u. - degarelix acetate - prostatske neoplazme - other hormone antagonists and related agents - degarelix accord is a gonadotrophin releasing hormone (gnrh) antagonist indicated:for treatment of adult male patients with advanced hormone-dependent prostate cancer. for treatment of high-risk localised and locally advanced hormone dependent prostate cancer in combination with radiotherapy. as neo-adjuvant treatment prior to radiotherapy in patients with high-risk localised or locally advanced hormone dependent prostate cancer.

Improvac Europska Unija - hrvatski - EMA (European Medicines Agency)

improvac

zoetis belgium sa - synthetic peptide analogue of gnrf conjugated to diptheria toxoid - imunološke za suidae - male pigs (from 8 weeks of age); female pigs (from 14 weeks of age) - male pigs:induction of antibodies against gnrf to produce a temporary immunological suppression of testicular function. for use as an alternative to physical castration for the reduction of boar taint caused by the key boar taint compound androstenone, in entire male pigs following the onset of puberty. drugi ključni čimbenik za svinjsku kosu, skatole, također može biti smanjen kao neizravni učinak. također su smanjene agresivne i seksualne (montirane) ponašanja. female pigs:induction of antibodies against gnrf to produce a temporary immunological suppression of ovarian function (suppression of oestrus) in order to reduce the incidence of unwanted pregnancies in gilts intended for slaughter, and to reduce the associated sexual behaviour (standing oestrus).